Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Immune disorders > MTA W1 > Flashcards

MTA W1 Flashcards

1
Q

Acción de los mecanismos de tolerancia

A

Eliminan e inactivan los linfocitos con alta afinidad por antígenos propios

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Riesgo implicado por la recombinación aleatoria en el desarrollo de linfocitos T y B

A

Reacciones contra las células del individuo que provocan daño/enfermedad al mismo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

La tolerancia es específica del ________ y ocurre por clones individuales de un mismo linfocito

A

Antígeno

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

V/F: la tolerancia solo puede inducirse frente a células extrañas

A

F: los tolerágenos pueden ser proteínas, células extrañas y antígenos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

¿Qué factores influyen en si un factor es inmunógeno o tolerágeno?

A
  • Exposición al antígeno durante la maduración del linfocito
  • Reconocimiento por linfocitos específicos en presencia o ausencia de respuestas inmunitarias innatas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tipo de tolerancia inducida en linfocitos autorreactivos inmaduros en los órganos linfáticos generadores

A

Tolerancia central

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tipo de tolerancia inducida en linfocitos autorreactivos inmaduros en zonas periféricas

A

Tolerancia periférica

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Función de la tolerancia central

A

Asegura que linfocitos maduros vírgenes sean incapaces de responder a antígenos propios expresados en los órganos linfáticos generadores

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Órganos linfáticos centrales o generadores

A

Timo - linfocitos T
MO - linfocitos B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mecanismo que impide la activación de los linfocitos potencialmente lesivos que escaparon de la tolerancia central

A

Tolerancia periférica

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Los antígenos en el timo y la médula ósea durante la maduración de los linfocitos son…

A

Antígenos propios ubicuos o muy diseminados

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mature auto-reactive periferic lymphocytes undergo…

A
  • Inactivation after being presented with the self-antigen
  • Death by apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the role of Tregs in periferic tolerance?

A

Active suppression of the activation of specific lymphocytes against self-antigens (and others)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treg mediated suppression takes place in…

A

Secondary lymphatic organs and extralymphatic tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Immunitary response against organisms of the microbiome and the fetus in cases of pregnancy are attributed to the regulation by:

A

Tregs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Anatomic barriers (eyes and testicles) and fisical barriers (keratin and mucus) provide ________ to antigens, meaning…

A
  • Protection
  • They don’t produce a response and are ignored instead
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Possible uses of the induction of immunitary tolerance

A
  • Avoidance of immunitary reactions in autoimmune and allergic diseases
  • Transplant rejection
  • Genotherapy
  • Promotion of stem cell transplant acceptance
  • Avoidance of reactions against external proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Mechanisms of peripheral tolerance affect ____ lymphocytes and consist of these 3 actions:

A
  • Mature
  • Anergy (functional unresponsiveness)
  • Suppression by T regs
  • Apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Inactivation upon re-exposure to an antigen in peripheral tissues

A

Anergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Suppresion sites of Tregs

A
  • Secondary lymphoid organs
  • Non-lymphoid tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Where does central tolerance of T lymphocytes takes place?

A

Thymus (during T cell maturation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the outcomes of high avidity self antigen recognition by T cells?

A
  • Apoptotic cell death (deletion or negative selection)
  • Development into regulatory T cells (CD4+ lineage)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

T or F: Negative selection affects only class I MHC-restricted T cells (CD8+)

A

F: it affects both classes of MHC (I and II) (CD8 and CD4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Double positive T cells go through negative selection in the ____, while newly generated single positive T cells go through it in the ______

Parts of the thymus

A
  • Cortex
  • Medulla
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Cells that express peripheral tissue-specific antigens in the thymus

A

MTECs (Medullary thymic epithelial cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is AIRE and how does it work?

A
  • Autoimmune regulator (transcription level)
  • Controls expression of tissue-specific antigens in METEC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Consequences of the absence of functional AIRE

A
  1. Antigens are not expressed in thymus
  2. Self-reactive CD4 and CD8 escape deletion, leading to maturation and the attack of target tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Syndrome related to absence of AIRE

A

APS1 (lymphocyte and antibody mediated injury to the parathyroids, adrenals, pancreatic islets and skin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What molecules do autoantibodies in APS1 target and neutralize?

A
  • IL-17
  • IL-22
  • IFN-1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

IL-17 deficiency predisposes to:

A

Mucocutaneous candidasis due to lack of antifungal defense

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Transcription regulator involved in elongation and chromatin remodelling that promotes expression of tissue-restricted antigens in the thymus

A

AIRE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

In central tolerance, high-affinity TCR signaling in immature T cells triggers:

A

Mitochondrial pathway of apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

How does signal interpretation differ in mature/immature T cells?

A
  • Immature = apoptosis
  • Mature = activation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What do non-deleted self-reactive CD4 T cells become and what is their action?

A
  • T regs
  • Leave the thymus and suppress immune responses to self antigens in peripheral tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

T or F: peripheral tolerance only conduces to tolerance of tissue-specific self antigens, especially those not abundant in the thymus

A

F: they may also induce unresponsiveness to foreign antigens when presented under tolarogenic conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

State in which mature CD4 T cells become unresponsive to an antigen after prolonged exposure without coestimulation or innate immunity

A

Anergy

Remember that these self-reactive T cells are not killed, just inactivated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

T cell activation requirements

A
  • Signal 1 (Antigen recognition by TCR)
  • Signal 2 (Co-stimulatory signals mainly via B7-1 and 2 binding to CD28)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Fate of anergic cells

A
  • Survival in a quiescent state for days or weeks
  • Cell death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

T-cell tolerance

Mechanisms of anergy

A
  • TCR-Induced signal blockade
  • Activation of ubiquitin ligases
  • Engagement of inhibitory receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

T-cell tolerance

Decreased TCR expression and the recruitment of inhibitory molecules to the TCR complex lead to _____________ and, therefore ___________

A

TCR-induced signal blockade –> anergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

T-cell tolerance

The recognition of self-antigens without coestimulation activates ubiquitin ligases. What do these molecules do?

A

Tag TCR associated proteins for proteolytic degradation, leading to loss of signaling moleculaes and defective T cell activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

T-cell tolerance

Important T cell ubiquitin ligase that is essential for mantaining unresponsiveness to self antigens

A

CBL-b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

T-cell tolerance

Key inhibitory receptors with physiological roles in self-tolerance

A
  • CTLA-4
  • PD-1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

T-cell tolerance

Inhibitory receptor that performs mainly in secondary lymphoid organs during the induction phase (priming) and acts constitutively on Tregs

A

CTLA-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

T-cell tolerance

What is the mechanism of action of CTLA-4?

A

It outcompetes CD28 for B7, binds B7-1 and 2 and removes B7 from APCs via transendocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

T-cell tolerance

While CTLA-4 is expressed constitutively high on Tregs, on recently activated T cells it is ________ expressed

A

Transiently

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

T-cell tolerance

This inhibitory receptor works mainly on peripheral tissues in the effector phase of t cells by inhibiting mostly CD8+

A

PD-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

T-cell tolerance

How does PD-1 work?

A

It inhibits kinase-dependent signals from CD28 and TCR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

T-cell tolerance

What cells express PD-L receptors?

A
  • APCs
  • Bone marrow APCs (PD-L2)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

T-cell tolerance

After engagement of PD-1 by PD-L1/2, what molecules are phosphorilated and what is their action?

A
  1. ITIM and ITSM
  2. ITIM and ITSM bind SHP2 phosphatase, resulting in the inhibition of kinase-dependent signaling from TCR-coreceptor and CD28
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

T-cell tolerance

Molecules expressed by Tregs

A

high levels of iL-2 receptor ą chain and FOXP3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

T-cell tolerance

Syndrome derived from loss-of-function mutations in FOXP3

A

IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

T-cell tolerance

Why does IPEX syndrome lead to fatal systemic autoimmune disease in children unless treated with HTSC?

A

It results in deficiency of Tregs, leading to self-tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

T-cell tolerance

Regulatory T Cells express these factors in order to control the diverse immune responses:

A
  • CD4+
  • FOXP3+
  • CD25+
  • CTLA-4
  • Low CD127 (IL-7 receptor)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

T-cell tolerance

T/F: In various immune responses, T regs can be induced to express the same chemokine receptors as effector T cells

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

T-cell tolerance

Sites of Treg generation

A
  • Thymus
  • Peripheral tissues (without srong innate immune responses and after inflammatory reactions)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

T-cell tolerance

What is the role of IL-2 in Treg maintenance?

A

It is essential for the generation, survival and functional competence of Tregs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

T-cell tolerance

Cytokine that promotes thymic differentiation of Tregs and is essential for their manteinance in the periphery

A

IL-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

T-cell tolerance

Transcription factor activated by IL-2 to enhance FOXP3 expression, leading to upregulation of Treg function-related genes

A

STAT5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

T-cell tolerance

TGF-B plays a role on Tregs action by:

A

Stimulating FOXP3 expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

T-cell tolerance

Primary targets of Tregs

A
  • Dendritic cells (inhibits their stimulatory capacity)
  • T cells (direct suppression)
  • B cell (suppresses their activation)
  • NK (supresses cell proliferation and differentiation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

T-cell tolerance

Key suppressive mechanisms of Tregs

A
  1. CTLA-4-mediated inhibition of co-stimulation
  2. Production of immunosuppressive cytokines
  3. IL-2 consumption (deprives other cells from it = no proliferation or differentiation of immune cells)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

T-cell tolerance

Immunosuppresive cytokines produced by Tregs

A
  • IL-10
  • TGF-B
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

T-cell tolerance

How does TGF-B inhibit immune cell activation?

A
  • Suppresses T cell proliferation and effector functions
  • Inhibits classical macrophage activation
  • Suppresses activation of neutrophils and endothelial cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

T-cell tolerance

Although TGF-B can inhibit the development of TH1 and TH2 it also has a dual role consisting of:

A
  • Promotion of Tregs (anti-inflammatory)
  • Promotion of Th17 cells (proinflammatory)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

T-cell tolerance

Transcription factor that induces B cell isotype switching to IgA

A

TGF-B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

T-cell tolerance

How does TGF-B promote tissue repair?

A

Stimulates:
* Collagen synthesis
* Matrix-modifying enzyme production
* Angiogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

T-cell tolerance

Because of its tissue repair abilities, TGF-B may have a pathologic role in fibrotic diseases such as:

A
  • Pulmonary fibrosis
  • Systemic sclerosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

T-cell tolerance

This interleukin produced by activated macrophages, DCs, Tregs, TH1/2 cells and some B lymphocytes controls innate immune reactions and cell-mediated immunity

A

IL-10

Acts as a negative feedback regulator!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

T-cell tolerance

IL-10 receptor

A

Type 2 cytokine receptor family

72
Q

T-cell tolerance

How does IL-10 regulate immune function?

A
  • Inhibits IL-12 production and secretion by DCs and macrophages
  • Inhibits IFN-y (by consequence)
  • Inhibits costimulatory and antigen-presenting molecules (MHC II on DCs and macrophages)
73
Q

T-cell tolerance

Factors that favor immune response

A
  1. Short-lived antigens (persistence)
  2. Subcutaneous or intradermal portal of entry
  3. Antigens with adjuvants that induce costimulators and cytokines
  4. Mature DCs with high levels of costimulators
74
Q

T-cell tolerance

Factors that favor tolerance to self-antigens

A
  1. Prolonged persistence that leads to antigen receptor engagement
  2. Intravenous or mucosal portal of entry
  3. Presence in generative lymphoid organs
  4. Antigens without adjuvants (low costimulators and cytokines)
  5. Immature/resting DCs
75
Q

T-cell tolerance

Resting DCs that present self-antigens continously, are in an immature state, express low levels of costimulators and travel to secondary lymphoid organs at a steady state tend to induce…

A
  • Anergy
  • Treg differentiation
  • Non-effector or memory T cells
76
Q

T-cell tolerance

Therapeutic interest of DCs

A

Manipulating DCs properties may offer ways to enhance or suppress immune responses

77
Q

Tolerance

Type of tolerance that occurs during B cell maturation in the bone marrow as the immature B cells express membrane IgM as their antigen receptor

A

Central tolerance

78
Q

B Central tolerance

Name the 3 mechanisms of central B cell tolerance

A
  • Receptor editing
  • Deletion
  • Anergy
79
Q

B Central tolerance

This mechanism is triggered by strong signaling and recognition of self antigens at high concentration

A

Receptor editing

80
Q

B Central tolerance

After strong recognition, immature B cells reactivate ____ and ____ to initiate new ______ recombination at _______ locus

Receptor editing

A
  • RAG1 and RAG2
  • VJ
  • Ig k light chain locus

Results in a new light chain + new BCR specificity

81
Q

B Central tolerance

What happens if initial Vk to Jk rearrangements fail?

Receptor editing

A
  • Try rearrangement at k locus on other chromosome
  • Then try at λ loci
82
Q

B Central tolerance

Tolerance mechanism that happens after strong self-antigen recognition by immature or transitional B cells and leads to apoptosis

83
Q

B Central tolerance

Deletion mechanism

A
  • Presumedly similar to mitochondrial apoptosis pathway in T cells

B cells attempt receptor editing first and die if it fails

84
Q

B Central tolerance

Tolerance mechanism triggered by **weak recognition ** of self antigens

Soluble antigens, low affinity interactions or limited BCR cross linking

85
Q

B Central tolerance

Anergy results in…

A
  • Functionally unresponsive B cells that exit the bone marrow in an unresponsive state
86
Q

B Central tolerance

Anergy mechanisms involve…

A
  • Downregulation of BCR expression
  • Block in antigen receptor signaling
87
Q

B peripheral tolerance

Requisit for B peripheral tolerance

A

That mature B cells in the periphery recognize tissue self antigens without specific helper T cells

Because of elimination or anergt

88
Q

B peripheral tolerance

Antigen recognition without additional stimuli results in B cell tolerance. Why is that?

A
  • T cells are not sufficient or inactive
  • Self antigens are not protein antigens
  • Self antigens do not activate complement or pattern recognition receptors
89
Q

B peripheral tolerance

Name 4 mechanisms of peripheral B cell tolerance

A
  • Anergy
  • Deletion
  • Signaling by inhibitory receptors
  • Regulation by regulatory T cells (Tregs)
90
Q

B peripheral tolerance

Anergic B cells require higher than normal levels of ____/ for survival. Since they can’t compete effectively with normal B cells, this inactivated cells have ________ lifespan and are ________ more rapidly.

A
  • BAFF/BLyS
  • Shorter
  • Eliminated
91
Q

B peripheral tolerance

In this tolerance mechanism, high avidity recognition of self antigens leads to apoptotic death via the mitochondrial pathway

92
Q

B peripheral tolerance

Deletion occurs in ________ B cells outside the bone marrow.

Many are autoreactive; most are deleted before maturation

A

Transitional

93
Q

B peripheral tolerance

What is the role of inhibitory receptors in B cell activation?

A

Inhibitory receptors prevent B cell activation by setting an activation treshold. They are engaged primarily by self antigens whereas foreign antigens provide signals through multiple pathways.

94
Q

B peripheral tolerance

The inhibitory receptors CD22 (Siglec-2) and FcyRIIB help regulate B cell activation by recruiting the enzyme ________, which dampens BCR signaling.

A

SHP1 (tyrosine phosphatase)

95
Q

B peripheral tolerance

CD22 (Siglec-2) binds to…

Receptor inhibition

A

Sialic acid-decorated proteins on B cell surface

96
Q

B peripheral tolerance

Defects in SHP1, LYN, FcyRIIB, or CD22 lead to…

A

Autoimmunity

97
Q

B peripheral tolerance

What happens when CD22 (Siglec-2) binds sialic acid–decorated proteins on the B cell surface?

A

CD22 dampens BCR signaling by recruiting SHP1 after its ITIMS are phosphorylated by LYN

98
Q

B peripheral tolerance

In this mechanism, Tfr enter the lymphoid follicles and limit T cell help to germinal center b cells

A

Regulation by follicular regulatory T cells

99
Q

B peripheral tolerance

Factors involved in the regulation by Tregs

A
  • Follicular T regs
  • Tregs
  • Control of Tfh cell number and activity
  • Prevention of promiscuous B cell activation
100
Q

B peripheral tolerance

Treg deficiency is associated with…

A

Autoantibody production

101
Q

Tolerance to commensal microbes and other foreign antigens

Why do commensal microbes not elicit immune respones despite beign foreign?

A
  • They do not invade epithelial barriers
  • Induce and activate Tregs (inhibit effector and memory T cell development)
102
Q

Tolerance to commensal microbes and other foreign antigens

Protein antigens + adjuvants favor __________

A

Immunity

Adjuvants stimulate innate immune responses + costimulator expression

103
Q

Tolerance to commensal microbes and other foreign antigens

Repeated antigen doses without adjuvants favor ______

A

Tolerance

Adjuvants stimulate innate immune responses and costimulator expression

104
Q

Oral tolerance

Oral tolerance consists of:

A

Oral administration of protein antigen + suppression of systemic humoral and cell mediated responses to that antigen

105
Q

Therapeutic tolerance induction

Possible applications of autoimmune diseases & their antigens

A
  • Type 1 diabetes (antigen: insulin)
  • Multiple sclerosis (antigen: myelin basic protein)
  • Rheumatoid arthritis (citrullinated peptides)
  • Allergies
106
Q

Therapeutic tolerance induction

This strategy includes small doses of self antigen-derived peptides in their aqueous form without adjuvants, leadig to T cell anergy or deletion and activation of Tregs

Strategies

A

Repeated administration of immunodominant peptides

Desensitization/peptide immunotherapy effective in allergic patients

107
Q

Therapeutic tolerance induction

Strategy of peptide linkage to immunogenic substrates such as nanoparticles or erythrocyte membranes; similar to aqueous peptide administration

A

Antigen coupled delivery systems

108
Q

Therapeutic tolerance induction

Strategy where B7 molecules are blocked using CTLA4-Ig (inhibits immune responses but may not induce long-lived tolerance)

A

Costimulatory blockade

109
Q

Mechanisms of autoimmunity

Contributing factors to autoimmunity

A
  • Genetic susceptibility
  • Environmental triggers (infections/local tissue injury)
  • Emerging factors
110
Q

Mechanisms of autoimmunity

What are the most important ways that environmental triggers induce autoimmunity?

A
  • Promote influx and activation if autoreactive lymphocytes
  • Tissue injury
  • Pro-inflammatory cytokine production
  • Activation of self-reactive tolerance
111
Q

General features of autoimmune disorders

Antigen distribution of systemic autoimmune diseases

A

Triggered by circulating self antigens forming immune complexes

Systemic lupus erythematosus SLE

112
Q

General features of autoimmune disorders

Antigen distribution of organ-specific autoimmune diseases

A

Caused by autoantibody or T cell responses against tissue-restricted self antigens

Myasthenia gravis, Type 1 diabetes, Multiple sclerosis

113
Q

General features of autoimmune disorders

Factors that contribute to chronicity, progressiveness and self perpetuating autoimmune diseases

A
  • Persistence of self-antigens
  • Activation of immune amplification mechanisms
  • Epitope spreading

ES –> tissue injury –> self antigens –> activation of autoreactive LC

Explains prolonged and worsening disease progression

113
Q

General features of autoimmune disorders

Effector mechanisms of tissue injury

A
  • Immune complexes
  • Circulating autoantibodies
  • Autoreactive T lymphocytes
  • Disease features depend on the dominant effector mechanism
115
Q

Immunologic abnormalities leading to autoimmmunity

Autoimmunity underlying causes

A

Imbalance between lymphocyte activation and control mechanisms

116
Q

Immunologic abnormalities leading to autoimmmunity

Failure of negative selection, receptor editing in B cells, apoptosis, inhibitory receptor function and Tregs contribute to…

A

Inadequate deletion or regulation of T or B cells

117
Q

Immunologic abnormalities leading to autoimmmunity

All individuals have self-reactive lymphocytes and, although tolerance is mantained by central selection processes + peripheral mechanisms, loss of tolerance can occur if…

A
  • Self-reactive lymphocytes mature and are not inactivated
  • APCs present self antigens in an immunogenic context
118
Q

Abnormal display of self antigens

Enzymatic modifications and cellular stress or injury lead to the presentation of ____, to which the immune is not tolerant

Structural changes

A

Neoantigens

Not previously recognized by the immune system

Ex. citrullination or post-translational modifications

119
Q

Inflammation or initial innate immune response

Infections or tissue injury trigger local (…) immune reactions. Name the effects of it.

A
  • Innate
  • Activation of APCs
  • Increased expression of costimulators
  • Overcome of regulatory mechanisms + excessive T cell activation
120
Q

T cells in autoimmunity

Why are T cells a major focus on recent research?

A
  1. Helper T cells regulate both cell-mediated + humoral responses to proteins
  2. Many autoimmune diseases are associated with specific MHC alleles
121
Q

T cells in autoimmunity

Failure of T cell self-tolerance results in

A
  • Tissue damage
  • Cell-mediated autoimmune diseases
  • Autoantibody production
122
Q

Genetic basis of autoimmunity

Types of genetic associations

A
  • Shared polymorfisms (general immune mechanisms)
  • Disease specific-loci (organ-specific damage or autoreactive lymphocytes)
123
Q

Genetic basis of autoimmunity

Genetics hypothesis

A

Disease develops when multiple susceptibility polymorphisms are coinherited in 1 individual

124
Q

Association of MHC alleles with autoimmunity

Genes with strongest associations with autoimmunity

A

MHC genes (HLA in humans)

125
Q

Association of MHC alleles with autoimmunity

Class (…) HLA, specifically HLA-(…) and HLA-(…) alleles are most commonly associated with autoimmune diseases.

A
  • Class II
  • DR
  • DQ
126
Q

Allele HLA-B27 (Class 1) is associated with

A

Ankylosing spondilitis

127
Q

RA, Type 1 diabetes, multiple sclerosis and systemic lupus erythematosus are associated with this class 2 allele

128
Q

Celiac disease is associated with these class 2 alleles

A

HLA-DQA1, HLA-DQB1

129
Q

Association of MHC alleles with autoimmunity

Linkage disequilibrium

A

Inheritance of alleles together more often than by chance

130
Q

Association of MHC alleles with autoimmunity

Disease-associated nucleotide polymorphisms encode polymorphic residues on MHC molecules. Name their influence:

A
  • Antigen presentation
  • T cell recognition
131
Q

Association of MHC alleles with autoimmunity

T/F: HLA expression is sufficient to cause disease

A

False, it is present in many healthy individuals

132
Q

Association of MHC alleles with autoimmunity

T/F: some alleles may be protective against autoimmune diseases

A

True

As in type 1 diabetes and rheumatoid arthritis

133
Q

Select non-HLA genes associated with autoimmune diseases

Gene associated with rheumatoid arthritis, type 1 diabetes, autoimmune thyroiditis and others.

It alters signaling in immune cells.

134
Q

Select non-HLA genes associated with autoimmune diseases

Gene associated with Crohn’s disease.

Works as a cytoplasmic sensor of bacterial peptidoglycans in intestinal epithelial cells

A

NOD2

  • Reduced NOD2 fx. = inadequate control of intestinal microbes = chronic intestinal inflammation
135
Q

Select non-HLA genes associated with autoimmune diseases

Alterations in complement proteins (C1q, C2, C4) are associated with this autoimmune disease

A

Systemic lupus erythematosus

136
Q

Select non-HLA genes associated with autoimmune diseases

Polymorphisms in IL-23 receptor are associated with

A

Increased risk for IBD and psoriasis

Other variables may be protective

137
Q

Select non-HLA genes associated with autoimmune diseases

Polymorphisms that affect expression or function of IL-2 receptor a chain (CD25) are associated with…

A

Multiple sclerosis, Type 1 diabetes

Impair Treg development or function

138
Q

Select non-HLA genes associated with autoimmune diseases

Polymorphisms in FcyRIIB are associated with (…) by impairing inhibitory signaling + reducing feedback inhibition of B cells

A

Systemic Lupus Erythematous

139
Q

Select non-HLA genes associated with autoimmune diseases

Polymorphisms in ATG16L1 (component of autophagy machinery) are associated with

A

Crohn’s disease

140
Q

Select non-HLA genes associated with autoimmune diseases

Polymorphic repeat sequences with the insulin gene are associated with Type 1 diabetes as they…

A

Reduce thymic expression of insulin = incomplete negative selection of insulin-specific T cells

Self-reactive T cells survive and attack B cells in pancreas

141
Q

Main mechanisms by which infections promote autoimmunity

Consequence of the infection of tissues and triggering of local innate immunity (leukocyte recruitment + activation of APCs)

Induction of local innate immune responses

A
  • Expression of costimulators
  • Secrete T cell activating cytokines
  • Breakdown of T cell tolerance
  • Activation of T cell specific for cell antigens
142
Q

Main mechanisms by which infections promote autoimmunity

Mechanisms by which microbial antigens cross-react with self antigens and produce a cross reactive response against self

A

Molecular mimicry

143
Q

Molecular mimicry involved in rheumatic fever

A

Rheumatic fever
Anti-strepto antibodies cross react with myocardial proteins, resulting in myocarditis

Streptococcal infections

144
Q

Microbiome and autoimmunity

The intestinal and cutaneous microbiome influence autoimmunity by…

A

Affecting maturation + activation of the immune system

Microbiome alterations change incidence and severity of autoimmune dis.

146
Q

What are the three essential mechanisms by which self-tolerance is maintained?

A

(1) Central tolerance (deletion of self-reactive T/B cells), (2) Peripheral tolerance (anergy, apoptosis, Treg suppression), (3) Immune privilege (restricted antigen presentation in certain tissues).

147
Q

What are the two major inhibitory receptors involved in peripheral tolerance, and how do they work?

A

CTLA-4 outcompetes CD28 for B7 binding, preventing T cell activation. PD-1 recruits phosphatases to suppress TCR signaling, reducing immune response intensity.

148
Q

How does defective apoptosis contribute to autoimmunity?

A

Accumulation of apoptotic debris leads to aberrant antigen presentation, activating autoreactive lymphocytes (e.g., defective Fas-FasL signaling in ALPS).

149
Q

What is molecular mimicry, and how does it lead to autoimmune disease?

A

Pathogens express antigens similar to self-proteins, leading to cross-reactivity (e.g., Group A Streptococcus M protein triggering rheumatic fever).

150
Q

What is bystander activation, and how does it promote autoimmunity?

A

Infection-induced inflammation activates nearby autoreactive lymphocytes without specific antigen engagement, breaking tolerance.

151
Q

What is the hallmark pathogenic mechanism in systemic lupus erythematosus (SLE)?

A

Autoantibodies against nuclear antigens form immune complexes, depositing in tissues and activating complement, causing inflammation.

152
Q

What are the key diagnostic autoantibodies in SLE?

A

Anti-dsDNA (specific, associated with nephritis), Anti-Smith (anti-Sm) (specific), and ANA (sensitive but nonspecific).

153
Q

Why is Type I IFN (e.g., IFN-α) central to SLE pathogenesis?

A

IFN-α enhances antigen presentation, stimulates autoreactive B cells, and skews T cell responses towards inflammation.

154
Q

How do TLRs contribute to SLE pathogenesis?

A

TLR-7 and TLR-9 recognize self-RNA/DNA from apoptotic cells, activating B cells and dendritic cells, promoting autoimmunity.

155
Q

How does hydroxychloroquine work in SLE?

A

Blocks endosomal acidification, preventing TLR activation by self-DNA/RNA, reducing B cell activation.

156
Q

What is the key autoantigen in Type 1 Diabetes (T1D), and how do CTLs contribute to β-cell destruction?

A

Glutamic acid decarboxylase (GAD65); CD8⁺ T cells kill pancreatic β-cells via perforin/granzyme and Fas-FasL pathways.

157
Q

What is the key cytokine driving Th1-mediated autoimmunity in T1D and multiple sclerosis (MS)?

A

IFN-γ enhances antigen presentation and activates macrophages, promoting tissue destruction.

158
Q

What is the main immunopathogenic mechanism in multiple sclerosis (MS)?

A

Myelin-specific CD4⁺ Th1 and Th17 cells infiltrate the CNS, causing demyelination and axonal damage.

159
Q

How does natalizumab treat MS?

A

Blocks α4-integrin, preventing T cell migration into the CNS.

160
Q

What autoantibodies define myasthenia gravis, and what is their effect?

A

Anti-ACh receptor antibodies block neuromuscular transmission, causing muscle weakness.

161
Q

What is the role of TSH receptor autoantibodies in Graves’ disease?

A

They stimulate thyroid hormone production, causing hyperthyroidism.

162
Q

How does Hashimoto’s thyroiditis differ from Graves’ disease at the immunopathogenic level?

A

Hashimoto’s involves CD8⁺ T cell-mediated thyroid destruction, while Graves’ involves stimulatory autoantibodies.

163
Q

What is the role of Th17 cells in autoimmune diseases like psoriasis and rheumatoid arthritis (RA)?

A

IL-17 and IL-22 recruit neutrophils, enhance inflammation, and promote tissue damage.

164
Q

How does TNF-α drive inflammation in RA?

A

TNF-α upregulates MMPs, increases leukocyte recruitment, and promotes synovial hyperplasia (pannus formation).

165
Q

How do TNF inhibitors (e.g., infliximab) treat RA, and what is a major side effect?

A

Block TNF-α signaling, reducing inflammation; risk of reactivating latent TB.

166
Q

What cytokine is the main therapeutic target in Giant Cell Arteritis (GCA)?

A

IL-6 (targeted by tocilizumab).

167
Q

How does rituximab (anti-CD20) work in autoimmune diseases like RA?

A

Depletes B cells, reducing autoantibody production.

168
Q

What is the most specific antibody for RA?

A

Anti-CCP (anti-citrullinated peptide antibodies).

169
Q

How does the failure of immune checkpoints contribute to autoimmune disease?

A

Loss of CTLA-4 or PD-1 function leads to unchecked T cell activation against self-antigens.

170
Q

What is IPEX syndrome, and what is its immunological defect?

A

FOXP3 mutation → defective Tregs → severe multi-organ autoimmunity.

171
Q

What is ALPS (Autoimmune Lymphoproliferative Syndrome), and what causes it?

A

Fas/FasL mutation, preventing T cell apoptosis, leading to lymphoproliferation and autoimmunity.

172
Q

What is the link between CTLA-4 blockade (e.g., ipilimumab) and autoimmunity?

A

Loss of peripheral tolerance, leading to immune-related adverse effects (colitis, dermatitis, hepatitis).

173
Q

Why do JAK inhibitors (e.g., tofacitinib) help in autoimmune diseases?

A

Block cytokine signaling (IL-6, IFN-γ, IL-23), reducing immune activation.

174
Q

How do B cell-depleting therapies like belimumab (anti-BAFF) work in SLE?

A

Reduce B cell survival, decreasing autoantibody production.

175
Q

What is the significance of immune complex deposition in SLE nephritis?

A

Triggers complement activation, leading to kidney inflammation and damage.

Immune disorders (4 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions